- Home
- FGEN vs LGL Comparison
FGEN vs LGL Comparison
Compare FGEN & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- LGL
- Stock Information
- Founded
- FGEN 1993
- LGL 1917
- Country
- FGEN United States
- LGL United States
- Employees
- FGEN N/A
- LGL N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- LGL Industrial Machinery/Components
- Sector
- FGEN Health Care
- LGL Technology
- Exchange
- FGEN Nasdaq
- LGL Nasdaq
- Market Cap
- FGEN 33.5M
- LGL 38.5M
- IPO Year
- FGEN 2014
- LGL N/A
- Fundamental
- Price
- FGEN $7.80
- LGL $7.51
- Analyst Decision
- FGEN Strong Buy
- LGL
- Analyst Count
- FGEN 1
- LGL 0
- Target Price
- FGEN $250.00
- LGL N/A
- AVG Volume (30 Days)
- FGEN 61.0K
- LGL 47.2K
- Earning Date
- FGEN 08-05-2025
- LGL 08-12-2025
- Dividend Yield
- FGEN N/A
- LGL N/A
- EPS Growth
- FGEN N/A
- LGL 204.51
- EPS
- FGEN N/A
- LGL 0.08
- Revenue
- FGEN $6,996,000.00
- LGL $4,322,000.00
- Revenue This Year
- FGEN N/A
- LGL N/A
- Revenue Next Year
- FGEN N/A
- LGL N/A
- P/E Ratio
- FGEN N/A
- LGL $99.26
- Revenue Growth
- FGEN N/A
- LGL 20.66
- 52 Week Low
- FGEN $4.50
- LGL $5.03
- 52 Week High
- FGEN $38.25
- LGL $9.74
- Technical
- Relative Strength Index (RSI)
- FGEN 67.08
- LGL 56.90
- Support Level
- FGEN $7.03
- LGL $7.51
- Resistance Level
- FGEN $5.73
- LGL $7.79
- Average True Range (ATR)
- FGEN 0.57
- LGL 0.36
- MACD
- FGEN 0.35
- LGL 0.01
- Stochastic Oscillator
- FGEN 100.00
- LGL 68.89
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.